Evaluation of myocardial and clinical beneficial effect of sevoflurane in intraoperative and postoperative myocardial revascularization surgery, compared with propofol

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud0 个研究点开始时间: 2013年8月14日最近更新: 2014年1月27日

适应症

试验速览

暂无简介。

•1. Elective off-pump CABG.
•2.EUROSCORE (European level of risk, useful in the perioperative period of cardiac surgery patients, validated medical and scientific level) under 8 (moderate risk in the perioperative cardiac).
•3. Anesthetic risk level according to the American Society of Anesthesia (ASA) of less than 4 (moderate anesthetic risk patient-high).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 100
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. History of adverse reaction to the various anesthetic drugs.
•2. Severe disease of any organ (lung, liver, kidney), diagnosed preoperatively.
•3. Combined surgery (eg valve repair or carotid surgery).
•4. Patients in hemodynamic instability.
•5. Heart failure or need for use of inotropes or vasoactive before surgery.
•6. Treatment with oral antidiabetics suspended at least 48 hours before.
•7. Treatment eufilina / theophylline before surgery.

发起方

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud